Rationalizing Antibiotic Use in Long-Term Care Facilities
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotics Use and Antimicrobial Stewardship".
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 3973
Special Issue Editor
Interests: rational use of antibiotics; respiratory tract infections; urinary tract infections; point-of-care tests; primary health care
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The excessive and inappropriate use of antibiotics is the main cause of antimicrobial resistance, which is particularly problematic in frail, older people who are susceptible to frequent and severe infections. Antimicrobial stewardship interventions are seldom carried out in long-term care facilities. In addition, a lack of infection prevention and control leads to antimicrobial over-prescription in this setting, perpetuating antimicrobial inappropriateness. Health-care-associated infections, mainly respiratory and urinary tract infections, some of which are caused by resistant bacteria, are common but could be reduced through antibiotic stewardship and improved hygiene.
Long-term care facilities usually lack health and care resources, which has a direct impact on the health of residents. Therefore, these nursing homes constitute the best target population for intervention initiatives aimed at reducing inappropriate antibiotic use. In this Special Issue, we are planning to compile original research articles, short communications, reviews, case reports, and perspectives with a focus on reducing antibiotic inappropriateness in health-care-associated infections by implementing interventions targeting health care professionals in long-term care facilities.
Dr. Carl Llor
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
